Bolsron Pharmaceuticals Private Limited
About Bolsron Pharmaceuticals Private Limited
Data last updated:
Bolsron Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India, recognised as a startup by DPIIT. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 15 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U85100RJ2019PTC064017. Its GSTIN is 08AAICB2844E1ZT (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sarjeeta Sharma and Dheeraj Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 49 Kamal Vatika Near Kalawala Vatika Road Sanganer, Jaipur, Rajasthan, India – 302029.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.07 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹6.23 Lakh (net margin -36.5%) and EBITDA of -₹5.94 Lakh (EBITDA margin -34.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 49 Kamal Vatika Near Kalawala Vatika Road Sanganer, Jaipur, Rajasthan, India – 302029
- IndustryHealthcare, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bolsron Pharmaceuticals Private Limited
The main business activity of Bolsron Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bolsron Pharmaceuticals Private Limited FY 2025 filings available
Bolsron Pharmaceuticals Private Limited reported revenue of ₹17.07 Lakh (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Bolsron Pharmaceuticals Private Limited
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bolsron Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹5.94 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹6.23 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bolsron Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -34.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -36.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bolsron Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Bolsron Pharmaceuticals Private Limited
Bolsron Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarjeeta Sharma | Director | 04 Mar 2022 | 4 Years 7 Months | Current |
| Dheeraj Kumar Sharma | Director | 15 Feb 2019 | 7 Years 7 Months | Current |
Charges & Borrowings of Bolsron Pharmaceuticals Private Limited
Bolsron Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bolsron Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Bolsron Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bolsron Pharmaceuticals Private Limited
Director changes at Bolsron Pharmaceuticals Private Limited
Bolsron Pharmaceuticals Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Sarjeeta Sharma ceased to be Additional Director on 30 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Bolsron Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bolsron Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bolsron Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bolsron Pharmaceuticals Private Limited
Bolsron Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAICB2844E1ZT | Rajasthan | Active | 01 Mar 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bolsron Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bolsron Pharmaceuticals Private Limited
Bolsron Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in human health activities, within the healthcare industry. It was incorporated on 15 February 2019 (7+ years old) and is registered under CIN U85100RJ2019PTC064017.
Bolsron Pharmaceuticals reported revenue of ₹17.07 Lakh for FY 2025 (down 8% YoY).
Bolsron Pharmaceuticals has 2 current directors:
- Sarjeeta Sharma - Director
- Dheeraj Kumar Sharma - Director
Bolsron Pharmaceuticals reported a net loss of ₹6.23 Lakh (net margin -36.5%) and EBITDA of -₹5.94 Lakh (EBITDA margin -34.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bolsron Pharmaceuticals is 3% over three years and 10% over five years. In the latest year (FY 2025) revenue fell 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Bolsron Pharmaceuticals is 08AAICB2844E1ZT, registered in Rajasthan.
The CIN (Corporate Identification Number) of Bolsron Pharmaceuticals is U85100RJ2019PTC064017. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bolsron Pharmaceuticals was incorporated on 15 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Jaipur.
Sarjeeta Sharma ceased to be Additional Director on 30 Sep 2022. Jagjeet Singh ceased to be Director on 07 Mar 2022. Juber Khan ceased to be Director on 07 Mar 2022. Bolsron Pharmaceuticals has 5 board changes on record in total.
Yes, Bolsron Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).